Plasmid type analysis Plasmid replicons were identified by ABRicate v1.01 ( using the PlasmidFinder 37 database with 90% identity and 80% query coverage cutoffs
According to CMS, the covered products are: Wegovy (semaglutide), all formulations, including the injection and the tablet Zepbound KwikPen (tirzepatide), the once-weekly injector pen only Foundayo (orforglipron), a once-daily pill, all formulations Important: Not every GLP-1 is covered under the Bridge
The losses concentrate on Monster's core everyday-utility occasions: long shifts, flavor, convenience-store grab, and the daily energy-boost trigger
A month's supply of Wegovy or Zepbound can cost $1,000 to $1,600 without insurance, making the question of whether Medicaid covers weight loss shots a matter of urgent financial concern for low-income patients